$NBIO - Dr. Ivan Babic, in charge of Nascent's R&D
Post# of 85277
(Total Views: 139)
Posted On: 07/19/2022 11:28:52 AM
$NBIO - Dr. Ivan Babic, in charge of Nascent's R&D, and the inventor listed on the patent, stated, "Allowance of the Pritumumab patent highlights the uniqueness of this naturally-derived antibody and the importance of the right experimental and storage conditions for maintaining its potency."
https://finance.yahoo.com/news/nascent-biotec...?.tsrc=rss
https://finance.yahoo.com/news/nascent-biotec...?.tsrc=rss
(0)
(0)Scroll down for more posts ▼